Abstract
Inclisiran (Leqvio) is a double‐stranded, siRNA cholesterol‐lowering agent for the treatment of primary hypercholesterolaemia or mixed dyslipidaemia. This article discusses its mode of action, efficacy and place in therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have